What Makes TROP2 a Promising Therapeutic Target for NSCLC?
hosted byProjects In Knowledge Inc. (PIK)What Makes TROP2 a Promising Therapeutic Target for NSCLC? is organized by Projects In Knowledge Inc. (PIK).
Release Date: Feb 13, 2023
Termination Date: Feb 12, 2024
Activity Goal:
The goal is to close existing professional gaps in the care of patients with NSCLC. To achieve this goal, we propose an initiative that includes comprehensive, continuously updated point-of-care education to help clinicians demonstrate: • Greater knowledge surrounding emerging data and clinical trial disclosures for TROP2-directed therapies in NSCLC • Greater knowledge regarding potential treatment-emergent toxicities associated with TROP2-directed therapies and strategies for monitoring, prevention, and management
Learning Objective(s):
• Evaluate the latest clinical evidence for various TROP2-directed therapeutic strategies in the management of advanced or metastatic non-small cell lung cancer.
Additional details will be posted as soon as information is available.
